Compared to HD, Holley et al. [19] reported a similar frequency of CD3+CD20+ cells in MS, whereas Von Essen et al. [13] described an increased frequency in both the CD4+ and CD8+ compartments of RR- and primary-progressive (PP-)MS. This evidence concerns the gene CD8A and myeloid sarcoma.